Literature DB >> 30869673

Dietary inulin alleviates diverse stages of type 2 diabetes mellitus via anti-inflammation and modulating gut microbiota in db/db mice.

Ke Li1, Li Zhang, Jing Xue, Xiaoli Yang, Xiaoying Dong, Liping Sha, Hong Lei, Xiaoxia Zhang, Lili Zhu, Zhen Wang, Xiaorong Li, Hao Wang, Ping Liu, Youping Dong, Lanjie He.   

Abstract

Type 2 diabetes mellitus (T2DM) is closely correlated with chronic low-grade inflammation and gut dysbiosis. Prebiotic inulin (INU) is conducive to modulate gut dysbiosis. However, the impact of dietary inulin on the diverse stages of T2DM remains largely unknown. In the present study, according to the fasting blood glucose (FBG) and oral glucose tolerance tests (OGTT), mice were randomly divided into six groups (15 mice per group): pre-diabetic group (PDM group); inulin-treated pre-diabetic group (INU/PDM group); early diabetic group (EDM group); inulin-treated early diabetic group (INU/EDM group); diabetic group (DM group); inulin-treated diabetic group (INU/DM group). All animal experiments were approved by the Ethics Committee of the General Hospital of Ningxia Medical University (No. 2016-232). After 6 weeks of inulin intervention, the mice were euthanized and the associated indicators were investigated. Dietary inulin significantly reduced FBG, body weights (BWs), glycated hemoglobin (GHb), blood lipid, plasma lipopolysaccharide (LPS), interleukin (IL)-6, tumor necrosis factor (TNF)-α and IL-17A in the three inulin-treated groups compared to the untreated groups. But for IL-17A, there remained no significant difference between the PDM group and the INU/PDM group. Moreover, the anti-inflammatory IL-10 showed significant alteration in the INU/PDM and INU/EDM groups, but no significant alteration in the INU/DM group. Sequencing analysis of the gut microbiota showed an elevation in the relative abundance of Cyanobacteria and Bacteroides and a reduction in the relative abundance of Ruminiclostridium_6 in three inulin-treated different stages of T2DM groups, as well as a reduction in the relative abundance of Deferribacteres and Tenericutes in the INU/DM group. A reduction in the relative abundance of Mucispirillum was detected in the INU/PDM and INU/EDM groups. Correlation analysis revealed that Cyanobacteria and Bacteroides abundance were positively correlated with IL-10; Deferribacteres, Tenericutes, Mucispirillum and Ruminiclostridium_6 abundance were closely related to IL-6, TNF-α or IL-17A respectively. Additionally, Mucispirillum and Ruminiclostridium_6 abundance were positively correlated with LPS. Taken together, dietary inulin alleviated the diverse stages of T2DM via suppressing inflammation and modulating gut microbiota.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30869673     DOI: 10.1039/c8fo02265h

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  40 in total

1.  Dietary Additives and Supplements Revisited: The Fewer, the Safer for Liver and Gut Health.

Authors:  Rachel Golonka; Beng San Yeoh; Matam Vijay-Kumar
Journal:  Curr Pharmacol Rep       Date:  2019-06-10

2.  Treating the Onset of Diabetes Using Probiotics Along with Prebiotic from Pachyrhizus erosus in High-Fat Diet Fed Drosophila melanogaster.

Authors:  Amrita Bhanja; Nibedita Nayak; Sumit Mukherjee; Parag Prakash Sutar; Monalisa Mishra
Journal:  Probiotics Antimicrob Proteins       Date:  2022-06-16       Impact factor: 5.265

3.  Maternal Genistein Intake Mitigates the Deleterious Effects of High-Fat Diet on Glucose and Lipid Metabolism and Modulates Gut Microbiota in Adult Life of Male Mice.

Authors:  Liyuan Zhou; Xinhua Xiao; Qian Zhang; Jia Zheng; Mingqun Deng
Journal:  Front Physiol       Date:  2019-07-30       Impact factor: 4.566

Review 4.  Targeting Gut Microbiota for the Prevention and Management of Diabetes Mellitus by Dietary Natural Products.

Authors:  Bang-Yan Li; Xiao-Yu Xu; Ren-You Gan; Quan-Cai Sun; Jin-Ming Meng; Ao Shang; Qian-Qian Mao; Hua-Bin Li
Journal:  Foods       Date:  2019-09-25

5.  Tibet plateau probiotic mitigates chromate toxicity in mice by alleviating oxidative stress in gut microbiota.

Authors:  Pengya Feng; Ze Ye; Huawen Han; Zhenmin Ling; Tuoyu Zhou; Shuai Zhao; Amanpreet Kaur Virk; Apurva Kakade; Abd El-Fatah Abomohra; Marwa M El-Dalatony; Ei-Sayed Salama; Pu Liu; Xiangkai Li
Journal:  Commun Biol       Date:  2020-05-15

6.  Resistant dextrin improves high-fat-high-fructose diet induced insulin resistance.

Authors:  Fan Hu; Yixin Niu; Xiaoyuan Xu; Qiuyue Hu; Qing Su; Hongmei Zhang
Journal:  Nutr Metab (Lond)       Date:  2020-05-15       Impact factor: 4.169

7.  Peanut skin extract ameliorates the symptoms of type 2 diabetes mellitus in mice by alleviating inflammation and maintaining gut microbiota homeostasis.

Authors:  Lan Xiang; Qiaobei Wu; Hiroyuki Osada; Minoru Yoshida; Wensheng Pan; Jianhua Qi
Journal:  Aging (Albany NY)       Date:  2020-07-22       Impact factor: 5.682

8.  Bifidobacterium animalis subsp. lactis A6 Alleviates Obesity Associated with Promoting Mitochondrial Biogenesis and Function of Adipose Tissue in Mice.

Authors:  Yanxiong Huo; Xuhong Lu; Xiaoyu Wang; Xifan Wang; Lingli Chen; Huiyuan Guo; Ming Zhang; Yixuan Li
Journal:  Molecules       Date:  2020-03-25       Impact factor: 4.411

9.  Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth.

Authors:  Yan Li; Lisa Elmén; Igor Segota; Yibo Xian; Roberto Tinoco; Yongmei Feng; Yu Fujita; Rafael R Segura Muñoz; Robert Schmaltz; Linda M Bradley; Amanda Ramer-Tait; Raphy Zarecki; Tao Long; Scott N Peterson; Ze'ev A Ronai
Journal:  Cell Rep       Date:  2020-02-11       Impact factor: 9.423

10.  "Adjusting Internal Organs and Dredging Channel" Electroacupuncture Ameliorates Insulin Resistance in Type 2 Diabetes Mellitus by Regulating the Intestinal Flora and Inhibiting Inflammation.

Authors:  Liying Zhang; Xinhua Chen; Haili Wang; Haipeng Huang; Mengyuan Li; Lin Yao; Shiqi Ma; Zhen Zhong; Hongmei Yang; Hongfeng Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-09       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.